Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
10:46am, Monday, 23'rd Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025
10:26am, Friday, 20'th Dec 2024
Investing in large-cap MedTech stocks like MCK, PEN, CAH and PEN can be profitable for investors in 2025.
Why ResMed (RMD) is a Top Value Stock for the Long-Term
10:41am, Friday, 13'th Dec 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
RMD or PODD: Which Is the Better Value Stock Right Now?
12:41pm, Thursday, 12'th Dec 2024
Investors interested in Medical - Products stocks are likely familiar with ResMed (RMD) and Insulet (PODD). But which of these two companies is the best option for those looking for undervalued stocks
5 Solid Dividend Growth Stocks to Buy Now
10:15am, Thursday, 12'th Dec 2024
InterDigital, ResMed, Greenbrier Companies, Charles River Associates and Kontoor Brands seem excellent choices for your portfolio.
Scoop Up These 3 GARP Stocks to Receive Handsome Returns
09:10am, Monday, 09'th Dec 2024
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. RMD, OUT and CTAS are some stocks that hold promise.
Here is Why Growth Investors Should Buy ResMed (RMD) Now
06:47am, Monday, 09'th Dec 2024
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
4 Medical Product Stocks to Buy From a Prospective Industry
10:45am, Wednesday, 04'th Dec 2024
An ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. RMD, HAE, PAHC and AGIO are well-poised to gain from the favorable fac
Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Canada Sleep Apnea Devices Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's offeri
Here's Why ResMed (RMD) is a Strong Momentum Stock
10:55am, Tuesday, 03'rd Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
My Top 15 High-Growth Dividend Stocks For December 2024
06:00am, Monday, 02'nd Dec 2024
The SPDR S&P 500 ETF Trust posted a strong gain of 5.96% in November, resuming its strong run in 2024. The Top 15 dividend growth stocks for December 2024 offer an average dividend yield of 1.2% and a
RMD vs. LMAT: Which Stock Is the Better Value Option?
12:40pm, Tuesday, 26'th Nov 2024
Investors looking for stocks in the Medical - Products sector might want to consider either ResMed (RMD) or LeMaitre Vascular (LMAT). But which of these two companies is the best option for those look
5 Top-Ranked Dividend Growth Stocks for Your Portfolio
09:55am, Monday, 25'th Nov 2024
Dividend investing is a popular choice among investors. It can provide a sense of security in times of market uncertainty or downturns.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
10:00am, Thursday, 21'st Nov 2024
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)
01:46pm, Wednesday, 20'th Nov 2024
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
